Global Cord Blood Cryopreservation Service Market Growth (Status and Outlook) 2025-2031

The global Cord Blood Cryopreservation Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Cord blood cryopreservation service involves the process of collecting, processing, and preserving stem cells found in the blood of a newborn"s umbilical cord for potential future medical use.

United States market for Cord Blood Cryopreservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cord Blood Cryopreservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cord Blood Cryopreservation Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cord Blood Cryopreservation Service players cover Cryo-Cell, Cordlife, Vita 34, LifeCell, Smart Cells, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cord Blood Cryopreservation Service Industry Forecast” looks at past sales and reviews total world Cord Blood Cryopreservation Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Cord Blood Cryopreservation Service sales for 2025 through 2031. With Cord Blood Cryopreservation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cord Blood Cryopreservation Service industry.

This Insight Report provides a comprehensive analysis of the global Cord Blood Cryopreservation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cord Blood Cryopreservation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cord Blood Cryopreservation Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cord Blood Cryopreservation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cord Blood Cryopreservation Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Cord Blood Cryopreservation Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Liquid Phase
Vapor Phase

Segmentation by Application:
Hospital
Biotechnology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cryo-Cell
Cordlife
Vita 34
LifeCell
Smart Cells
ViaCord (PerkinElmer)
Americord
CordVida
StemCyte
Cells4Life
New England Cord Blood Bank
CryoHoldco
AlphaCord
Cord Blood Registry (CBR)
Lifeline
StemLife
Landfar Bio-medicine
SALIAI Stemcell Science and Technology
Vcanbio Cell & Gene Engineering

Please note: The report will take approximately 2 business days to prepare and deliver.